Cite
MLA Citation
R Reilmann et al.. “N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington's Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial.” Journal of neurology, neurosurgery and psychiatry, vol. 85, n.d., p. A102. http://access.bl.uk/ark:/81055/vdc_100135554143.0x000035